NYXH - Nyxoah SA
IEX Last Trade
8
-0.340 -4.250%
Share volume: 16,186
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$8.34
-0.34
-4.08%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.79%
1 Month
-3.38%
3 Months
-12.76%
6 Months
-42.94%
1 Year
3.23%
2 Year
-3.61%
Key data
Stock price
$8.00
DAY RANGE
N/A - $8.30
52 WEEK RANGE
$4.00 - $20.00
52 WEEK CHANGE
$0.07
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Olivier Taelman
Region: US
Website: https://www.nyxoah.com/
Employees: 2,021
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: https://www.nyxoah.com/
Employees: 2,021
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).
Recent news